How the COVID-19 outbreak is reshaping the diagnostics industry

Hear from Duncan Porter, Senior Director and leader of the Clinical Microbiology segment at Thermo Fisher Scientific, as he discusses the challenges of treating an ageing population and how the COVID-19 pandemic has driven innovation in the diagnostics field. Porter highlights how the diagnostics field is changing from a reactive front to a proactive front, where diagnostics are becoming an integrated part of healthcare delivery.

This video is the second installment in our four-part series exploring the diagnostic labs of the future. Follow the links below for the complete series:

Rapid antimicrobial susceptibility testing (AST) on the front line

How the COVID-19 outbreak is reshaping the diagnostics industry

Shaping the future of the UK diagnostics industry while ensuring continuity of supply

From qPCR to serology testing: Discover how scientists are keeping up with COVID-19